arrow
S

Stephen C. Strother

rotman research institute
H指数:60
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics

与认知、不良生活事件、自伤行为、代谢组学和遗传学相关的大脑解剖学维度在重度抑郁症中的关联

2025-11-150
OAAI
Multi-Voxel pattern analysis for characterizing functional connectivity and neurocognitive function in major Depression: A CAN-BIND-1 Report

多体素模式分析用于表征重度抑郁症的功能连接和神经认知功能:一份CAN-BIND-1报告

2025-07-100
OAAI
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

唐氏综合症中Tau蛋白病理的PET成像及其与淀粉样蛋白,纵向MRI和认知变化的关系: 唐氏综合症生物标志物计划 (DSBI) 的结果

2025-02-0676
PREAI
Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume
2024-10-120
OAAI
An empirical analysis of structural neuroimaging profiles in a staging model of depression
2024-04-011
PRE
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

轻度认知障碍,脑血管疾病和帕金森病患者的神经精神症状和脑形态: 一项横断面和纵向研究

2024-03-161
PRE
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report
2024-01-012
PRE
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases

在神经退行性疾病和脑血管疾病中,白质高信号和较小的皮质厚度与神经精神症状有关。

2023-06-2010
OAAI
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study
2023-03-067
OAAI
Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases

跨多种神经退行性疾病的抗扫视行为的认知相关性

2023-03-0212
OAAI
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study

反应抑制和预测对药物和认知行为疗法治疗重度抑郁症的反应: 加拿大抑郁症生物标志物整合网络研究

2023-02-015
PRE
Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease

白质的淀粉样蛋白PET: 与痴呆和小血管疾病患者的自由水,纤维完整性和认知的关系

2023-01-257
OAAI
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
2023-01-2310
OAAI
Gray matter volume drives the brain age gap in schizophrenia: a SHAP study
2023-01-0919
OAAI
The development of the pediatric stroke neuroimaging platform (PEDSNIP)
2023-01-010
OAAI
Comparison of Diffusion Tensor Imaging Metrics in Normal-Appearing White Matter to Cerebrovascular Lesions and Correlation with Cerebrovascular Disease Risk Factors and Severity

正常脑白质与脑血管病变扩散张量成像指标的比较及其与脑血管病危险因素和严重程度的相关性

2022-10-217
OAAI